Bo Lei Selected Research

Lanthanoid Series Elements (Lanthanides)

7/2021	Multimodal channel cancer chemotherapy by 2D functional gadolinium metal-organic framework.
1/2020	Construction of high quality ultrathin lanthanide oxyiodide nanosheets for enhanced CT imaging and anticancer drug delivery to efficient cancer theranostics.
1/2019	A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties.
1/2018	Self-Assembled Peptide-Lanthanide Nanoclusters for Safe Tumor Therapy: Overcoming and Utilizing Biological Barriers to Peptide Drug Delivery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Lei Research Topics

Disease

36	Neoplasms (Cancer) 07/2022 - 09/2005
21	Inflammation (Inflammations) 02/2022 - 07/2012
12	Infections 02/2022 - 01/2015
12	Uveitis 04/2021 - 01/2011
10	Wounds and Injuries (Trauma) 09/2022 - 01/2018
8	Leukemia 01/2021 - 01/2015
7	Breast Neoplasms (Breast Cancer) 11/2021 - 04/2016
6	Neoplasm Metastasis (Metastasis) 04/2020 - 04/2016
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2019 - 04/2015
4	Glaucoma 08/2022 - 09/2017
4	Colonic Neoplasms (Colon Cancer) 06/2022 - 01/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 10/2006
4	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2020 - 01/2012
4	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 06/2017 - 11/2010
3	Retinal Diseases 01/2022 - 01/2013
3	Retinoschisis (Retinoschisis, Juvenile) 01/2022 - 01/2018
3	Macular Degeneration (Age-Related Maculopathy) 10/2021 - 01/2013
3	Cicatrix (Scar) 08/2021 - 01/2019
3	Ganglion Cysts (Ganglion) 01/2021 - 01/2010
3	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 10/2019 - 02/2018
3	Hepatocellular Carcinoma (Hepatoma) 08/2019 - 04/2016
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2016 - 01/2016
3	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 09/2014 - 07/2012
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2013 - 11/2012
3	Retinal Degeneration 02/2011 - 07/2004
2	Hemorrhage 09/2022 - 04/2015
2	Pain (Aches) 07/2022 - 06/2022
2	Necrosis 01/2022 - 01/2014
2	Liver Diseases (Liver Disease) 12/2021 - 10/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2019
2	Body Weight (Weight, Body) 03/2021 - 05/2014
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021 - 02/2011
2	Multiple Myeloma 10/2019 - 12/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 11/2012
2	Lung Neoplasms (Lung Cancer) 01/2019 - 02/2018
2	Thrombocytopenia (Thrombopenia) 12/2018 - 04/2015
2	Cataract (Cataracts) 12/2018 - 08/2012
2	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2018 - 10/2006
2	Hypersensitivity (Allergy) 04/2016 - 01/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2016 - 12/2015

Drug/Important Bio-Agent (IBA)

15	Retinaldehyde (Retinal)IBA 08/2022 - 02/2011
13	Pharmaceutical PreparationsIBA 06/2022 - 01/2015
10	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2015
9	HydrogelsIBA 09/2022 - 01/2019
9	Peptides (Polypeptides)IBA 06/2022 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 04/2021 - 10/2006
8	Biocompatible Materials (Biomaterials)IBA 06/2022 - 08/2018
7	AntigensIBA 06/2019 - 10/2011
6	Citric Acid (Citrate)FDA LinkGeneric 06/2022 - 01/2019
6	CytokinesIBA 01/2022 - 01/2015
6	EndotoxinsIBA 04/2021 - 05/2014
5	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2016
5	LipopolysaccharidesIBA 04/2021 - 05/2014
5	CollagenIBA 12/2020 - 01/2018
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 12/2020
4	Lanthanoid Series Elements (Lanthanides)IBA 07/2021 - 01/2018
4	CateninsIBA 01/2021 - 01/2015
4	Biological ProductsIBA 12/2018 - 09/2015
4	Angiotensin-Converting Enzyme 2IBA 02/2016 - 05/2014
3	Glycerol (Glycerine)FDA LinkGeneric 01/2022 - 02/2018
3	MicellesIBA 01/2022 - 09/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
3	CadmiumIBA 12/2021 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 10/2019 - 01/2015
3	Interleukin-17 (Interleukin 17)IBA 06/2019 - 01/2012
3	PolymersIBA 01/2019 - 09/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 07/2012
3	diminazene aceturateIBA 02/2016 - 05/2014
3	Neuroprotective AgentsIBA 01/2015 - 08/2004
3	AdiponectinIBA 01/2013 - 09/2012
2	MetalsIBA 09/2022 - 02/2022
2	Ethanol (Ethyl Alcohol)IBA 07/2022 - 10/2011
2	InterleukinsIBA 01/2022 - 01/2014
2	erucylphosphocholineIBA 01/2022 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021
2	SmokeIBA 10/2021 - 10/2019
2	Retinal Pigments (Pigments, Visual)IBA 04/2021 - 01/2010
2	Streptozocin (Streptozotocin)FDA Link 03/2021 - 12/2012
2	Amino Acids FDA Link 12/2020 - 12/2018
2	Chimeric Antigen ReceptorsIBA 10/2019 - 12/2018
2	Long Noncoding RNAIBA 01/2019 - 04/2016
2	Complement System Proteins (Complement)IBA 01/2019 - 07/2014
2	Circular RNAIBA 01/2019 - 01/2019
2	KH902 fusion proteinIBA 01/2017 - 01/2015
2	Angiotensin IIIBA 05/2014 - 01/2012

Therapy/Procedure

26	Therapeutics 12/2022 - 01/2012
10	Drug Therapy (Chemotherapy) 10/2021 - 04/2015
5	Injections 06/2022 - 12/2020
3	Precision Medicine 07/2021 - 01/2019
2	Analgesia 07/2022 - 01/2021
2	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2022 - 01/2021
2	Intravitreal Injections 08/2021 - 05/2014
2	Photothermal Therapy 01/2020 - 01/2019
2	Immunotherapy 10/2019 - 01/2019
2	Induction Chemotherapy 01/2019 - 01/2016
2	Phacoemulsification 12/2018 - 08/2012
2	Intraperitoneal Injections 01/2015 - 05/2014